Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,341,842
-$325,396 QoQ
Shares Held
160,802
-15.4% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,399 across 136 Biotechnology names. TGTX ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,341,842 | 160,802 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,667,238 | 190,112 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,660,595 | 212,058 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,774,037 | 188,220 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,170,779 | 181,861 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,975,501 | 331,412 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,963,569 | 340,469 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,994,589 | 336,964 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,312,553 | 546,519 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,754,832 | 571,126 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,163,157 | 856,837 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,514,795 | 302,528 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,264,846 | 483,035 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,893,545 | 751,779 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,577,403 | 773,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,598,471 | 611,405 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,778,513 | 607,625 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,046,446 | 318,234 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,480,954 | 104,596 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,678,798 | 69,059 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,222,844 | 66,864 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,147,197 | 22,053 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,131,514 | 79,653 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,082,250 | 55,557 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $105,553 | 10,727 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||